Consumer Cyclical
Live Price
Offline$13.21
-1.71% today
1Y Change
-27.80%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
XPeng Inc. (XPEV) is a Consumer Cyclical stock with a market cap of $104.20B and listed on NYSE. The stock last traded around $13.21 and down 27.8% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +82.6%, EPS growth of +61.1%, a dividend yield of 0.0%. What stands out right now is revenue +82.6%, EPS +61.1%, free cash flow +210.6% with operating margin -4.8% and ROIC -6.9%. Valuation is more restrained than many high-expectation growth names at price/sales 1.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines XPEV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XPEV
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XPEV Max Drawdown
-50.69%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XPEV and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$21.0B
-21.8% YoY
FY Net Income
-$4.9B
+46.8% YoY
Free Cash Flow
-$1.5B
+72.2% YoY
Revenue Growth
+82.6%
EPS Growth
+61.1%
Gross Margin
18.9%
Net Margin
-1.5%
Income statement
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 74.6B | 40.9B | 30.7B | 26.9B | 21.0B |
| Gross Profit | 14.1B | 5.8B | 451M | 3.1B | 2.6B |
| Operating Income | -4.3B | -6.7B | -10.9B | -8.7B | -6.6B |
| EBITDA | -4.3B | -2.9B | -8.0B | -7.6B | -3.9B |
| Net Income | -1.1B | -5.8B | -10.4B | -9.1B | -4.9B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 24.0B | 18.6B | 21.1B | 14.6B | 11.0B |
| Total Assets | 103.2B | 82.7B | 84.2B | 71.5B | 65.7B |
| Total Liabilities | 72.8B | 51.4B | 47.8B | 34.6B | 23.5B |
| Shareholder Equity | 30.4B | 31.3B | 36.3B | 36.9B | 42.1B |
| Total Debt | 37.4B | 15.9B | 15.4B | 12.8B | 5.1B |
| Net Debt | 13.4B | -2.6B | -5.7B | -3.5B | -7.8B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
140M
+87.2% YoY
Capital Expenditures
1.4B
+68.4% YoY
Free Cash Flow
1.5B
+72.2% YoY
Key ratios
Gross Margin
18.9%
Operating Margin
-4.8%
Net Margin
-1.5%
ROE
-3.8%
Debt / Equity
1.01x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.